Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
In the time-to-event analysis, the rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke among patients with type ...
Publications
3 shownDesign of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
LEADER commenced in September 2010, and enrollment concluded in April 2012. There were 9,340 patients enrolled at 410 sites in 32 countries. The mean age of patients was 64.3 ± ...
Is There a Link Between Liraglutide and Pancreatitis? A Post Hoc Review of Pooled and Patient-Level Data From Completed Liraglutide Type 2 Diabetes Clinical Trials
OBJECTIVE To report the incidence of pancreatitis in type 2 diabetes trials of liraglutide and details of all pancreatitis cases. RESEARCH DESIGN AND METHODS Data from Novo Nord...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 7,039
- Institution
- George Washington University
External Links
Identifiers
- ORCID
- 0000-0002-6714-6974
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.